Skip to content
★ Sign in to follow
OB

Ocean Biomedical, Inc. Stock: price and insider trades · United States

Ocean Biomedical, Inc.: what insiders have been doing

Ocean Biomedical, Inc. has a thin disclosure history in our data (latest filing: 6 October 2023). New filings will appear here as soon as they are published. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Insider Decl.
17
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2024

FY ended December 2024 · cache

US$0.00
Analyst consensus
·
Income statement
EBITDA-US$7.4M
Net income-US$9.5M0.0% margin
Valuation
Beta0.38
Balance sheet & cash
Total debtUS$16.3M
Free Cash Flow-US$4.2M
Profitability & ownership
ROA-114.9%
% insiders10.3%
% institutions0.0%
Last declaration on 6 October 2023
Declarations17 total
  • ●
    DirectorExecutives
    0SEC
    500,000 sharesCommon Stock, par value $0.0001SEC:0001493152-23-036588:0
  • ●
    DirectorExecutives
    0SEC
    21,252 sharesCommon Stock, par value $0.0001SEC:0001493152-23-008972:0
  • ●
    DirectorExecutives
    0SEC
    1,050,000 sharesCommon Stock, par value $0.0001SEC:0001493152-23-008973:0
  • ●
    DirectorExecutives
    0SEC
    469,300 sharesCommon Stock, par value $0.0001SEC:0001493152-23-006622:1
  • ●
    DirectorExecutives
    0SEC
    258,200 sharesCommon Stock, par value $0.0001SEC:0001493152-23-006622:2
  • ●
    DirectorExecutives
    0SEC
    80,000 sharesCommon Stock, par value $0.0001SEC:0001493152-23-006621:0
  • ●
    DirectorExecutives
    0SEC
    2,625,000 sharesCommon Stock, par value $0.0001SEC:0001493152-23-006622:0
  • ◆
    DirectorExecutives
    228M USD0SEC
    22,842,756 shares@ US$10.00Class A Common Stock, par value $0.0001SEC:0001493152-23-005367:1
  • ●
    DirectorExecutives
    0SEC
    456,852 sharesClass A Common Stock, par value $0.0001SEC:0001493152-23-005367:2
  • ●
    DirectorExecutives
    0SEC
    456,852 sharesCommon Stock, par value $0.0001SEC:0001493152-23-005367:3
  • ●
    DirectorExecutives
    0SEC
    22,842,756 sharesClass A Common Stock, par value $0.0001SEC:0001493152-23-005367:4
  • ●
    DirectorExecutives
    0SEC
    22,842,756 sharesCommon Stock, par value $0.0001SEC:0001493152-23-005367:5
  • ●
    DirectorExecutives
    0SEC
    2,625,000 sharesClass A Common Stock, par value $0.0001SEC:0001493152-23-005358:1
  • ●
    DirectorExecutives
    0SEC
    3,990,000 sharesClass A Common Stock, par value $0.0001SEC:0001493152-23-005358:2
  • ●
    DirectorExecutives
    0SEC
    3,990,000 sharesCommon Stock, par value $0.0001SEC:0001493152-23-005358:3
  • ◆
    DirectorExecutives
    5M USD19SEC
    456,852 shares@ US$10.00100.0% of flowClass A Common Stock, par value $0.0001SEC:0001493152-23-005367:0
  • ◆
    DirectorExecutives
    0SEC
    1,365,000 sharesClass A Common Stock, par value $0.0001SEC:0001493152-23-005358:0

17 of 17 declarations

About Ocean Biomedical, Inc.

Ocean Biomedical, Inc. is a biotechnology company focused on developing innovative treatments for serious diseases. It is listed on NASDAQ under the ticker OCEA.